Inventor · name-matched record
CHEN SHUHUI
21 granted patents·4 pending applications·0 citations·filing 2020–2025
87Inventor score
Files withMEDSHINE DISCOVERY INC5CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2CISEN PHARMACEUTICAL CO LTD2BASECURE THERAPEUTICS LLC1BREAKTHROUGH PHARMACEUTICALS INC1
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
25 records- 0165US2026071220A1Conjugate of nucleotide analog-containing double-stranded rnai analogBASECURE THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 0263US2026055107A1Series of nitrogen-containing bridged heterocyclic compounds and preparation method thereforCMS RES & DEVELOPMENT PTE LTD·Filed 2023·Application pending·0 cites
- 0360US12516057B2Crystalline form of TLR8 agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Granted Jan 6, 2026·0 cites·20 claims
- 0459US12590082B2Fused tricyclic derivative and pharmaceutical application thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Granted Mar 31, 2026·0 cites·20 claims
- 0558US12552787B2Quinazoline compoundMEDSHINE DISCOVERY INC·Filed 2021·Granted Feb 17, 2026·0 cites·10 claims
- 0657US12565477B2Preparation method for chlorinated compoundJIANGSU KANION PHARMACEUTICAL CO LTD·Filed 2021·Granted Mar 3, 2026·0 cites·13 claims
- 0757US2026085094A1Stapled peptide and use thereofJIANGSU DEYUAN PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0856US12577246B2Indoline compoundZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD·Filed 2022·Granted Mar 17, 2026·0 cites·19 claims
- 0956US12570653B2Pyrimidine ring compoundMEDSHINE DISCOVERY INC·Filed 2021·Granted Mar 10, 2026·0 cites·20 claims
- 1054US12565480B2Thiophene derivatives as xanthine oxidase inhibitors and application thereofTONGHUA DONGBAO PHARMACEUTICAL CO LTD·Filed 2020·Granted Mar 3, 2026·0 cites·6 claims
- 1154US12552812B2Pyridone multiple-membered ring derivatives and use thereofPHAENO THERAPEUTICS CO LTD·Filed 2022·Granted Feb 17, 2026·0 cites·20 claims
- 1254US12545648B2Benzopyrazole compoundMEDSHINE DISCOVERY INC·Filed 2020·Granted Feb 10, 2026·0 cites·16 claims
- 1352US12595259B2Aminopyridine compoundZHUHAI UNITED LABORATORIES CO LTD·Filed 2021·Granted Apr 7, 2026·0 cites·18 claims
- 1452US12583841B2Tetrahydropyrrolocyclic compound and application thereofBREAKTHROUGH PHARMACEUTICALS INC·Filed 2022·Granted Mar 24, 2026·0 cites·11 claims
- 1552US12583846B22H-benzopyran derivatives as CRAC inhibitorsCISEN PHARMACEUTICAL CO LTD·Filed 2020·Granted Mar 24, 2026·0 cites·16 claims
- 1652US12539335B2Tricyclic polypeptide conjugated drug and use thereofCONJUSTAR ZHUHAI BIOLOGICS CO LTD·Filed 2022·Granted Feb 3, 2026·0 cites·9 claims
- 1752US12522616B2Thiazololactam compound as ERK inhibitor and use thereofD3 BIO WUXI CO LTD·Filed 2020·Granted Jan 13, 2026·0 cites·18 claims
- 1851US12577253B25,6-dihydrothieno[3,4-h]quinazoline compoundSHANGHAI FOSUN PHARMACEUTICAL IND DEVELOPMENT CO LTD·Filed 2022·Granted Mar 17, 2026·0 cites·13 claims
- 1951US12516070B2Fused ring derivatives and use thereof in pharmacyCISEN PHARMACEUTICAL CO LTD·Filed 2021·Granted Jan 6, 2026·0 cites·16 claims
- 2051US2026015364A1Piperazine bridge-substituted heterocyclic pyrimidine compoundMEDSHINE DISCOVERY INC·Filed 2023·Application pending·0 cites
- 2150US12565481B26,7-dimethoxy-3-(pyridin-2-yl)quinoline compounds for inhibiting RETGUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY·Filed 2021·Granted Mar 3, 2026·0 cites·18 claims
- 2250US12552789B21H-pyrrolo[2,3-c]pyridine compounds and application thereofJUMBO DRUG BANK CO LTD·Filed 2021·Granted Feb 17, 2026·0 cites·18 claims
- 2350US12534477B2Compound having KHK inhibitory effectHANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO LTD·Filed 2020·Granted Jan 27, 2026·0 cites·18 claims
- 2448US12552813B2Heterocyclic substituted pyrimidopyran compound and use thereofMEDSHINE DISCOVERY INC·Filed 2025·Granted Feb 17, 2026·0 cites·30 claims
- 2546US12516049B2Sulfonylurea ring substituted monocyclic β-lactam antibioticsSUZHOU ERYE PHARMACEUTICAL CO·Filed 2020·Granted Jan 6, 2026·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when CHEN SHUHUI files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →